Previous Article | Next Article 
Infection and Immunity, June 2000, p. 3587-3593, Vol. 68, No. 6
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Cooperation between Reactive Oxygen and Nitrogen
Intermediates in Killing of Rhodococcus equi by
Activated Macrophages
Patricia A.
Darrah,1
Mary K.
Hondalus,2
Quiping
Chen,3
Harry
Ischiropoulos,3 and
David M.
Mosser1,*
Department of Microbiology and Immunology,
Temple University School of Medicine, Philadelphia, Pennsylvania
191401; School of Public Health, Harvard
University, Boston, Massachusetts2; and
the Stokes Research Institute, University of Pennsylvania,
Philadelphia, Pennsylvania 191033
Received 7 January 2000/Returned for modification 1 March
2000/Accepted 16 March 2000
 |
ABSTRACT |
Rhodococcus equi is a facultative intracellular
bacterium of macrophages which can infect immunocompromised humans and
young horses. In the present study, we examine the mechanism of host defense against R. equi by using a murine model. We show
that bacterial killing is dependent upon the presence of gamma
interferon (IFN-
), which activates macrophages to produce reactive
nitrogen and oxygen intermediates. These two radicals combine to form
peroxynitrite (ONOO
), which kills R. equi.
Mice deficient in the production of either the high-output nitric oxide
pathway (iNOS
/
) or the oxidative burst
(gp91phox
/
) are more susceptible to lethal
R. equi infection and display higher bacterial burdens in
their livers, spleens, and lungs than wild-type mice. These in vivo
observations, which implicate both nitric oxide (NO) and superoxide
(O2
) in bacterial killing, were reexamined in
cell-free radical-generating assays. In these assays, R. equi remains fully viable following prolonged exposure to high
concentrations of either nitric oxide or superoxide, indicating that
neither compound is sufficient to mediate bacterial killing. In
contrast, brief exposure of bacteria to ONOO
efficiently
kills virulent R. equi. The intracellular killing of
bacteria in vitro by activated macrophages correlated with the
production of ONOO
in situ. Inhibition of nitric oxide
production by activated macrophages by using
NG-monomethyl-L-arginine blocks
their production of ONOO
and weakens their ability to
control rhodococcal replication. These studies indicate that
peroxynitrite mediates the intracellular killing of R. equi
by IFN-
-activated macrophages.
 |
INTRODUCTION |
Rhodococcus equi is a
gram-positive, facultative intracellular coccobacillus which can cause
pneumonia in immunocompromised people, especially individuals with AIDS
or those undergoing immunosuppressive therapy. The organism is thought
to be delivered to the lungs via inhalation and grows primarily, if not
exclusively, within host macrophages (15, 30). In young
horses (foals), R. equi can cause severe pneumonia or,
occasionally, septic arthritis or osteomyelitis (13). A
number of in vitro studies have demonstrated that resident macrophages
isolated from different species and from various anatomical locations
can support the intracellular growth of R. equi (reviewed in
reference 15).
Some previous studies have suggested that humoral immune responses can
contribute to host defense against R. equi. Antibody levels
in adult horses generally correlate with resistance to clinical
infection (31), and passive immunization with immune sera
can protect susceptible foals against infection (28).
However, adoptive transfer experiments and studies in mice which have
been genetically or experimentally depleted of T cells or cytokines (22, 23, 36, 39) argue for the importance of cell-mediated immunity in host defense against R. equi. Furthermore, the
emergence of this organism as an opportunistic pathogen in AIDS
patients (15) confirms the importance of cell-mediated
immunity. Thus, in both the murine model of experimental infection and
the human experience, the generation of Th1-type immune responses
correlates with disease resolution and a failure to mount these
responses is generally associated with poor clinical outcomes
(23).
It has been well established in a variety of model systems that
immunological activation of macrophages results in enhanced microbicidal activities (35). Activated macrophages exhibit an increase in the secretion of both reactive oxygen intermediates (ROIs) and reactive nitrogen intermediates (RNIs) (reviewed in reference 37). ROIs are produced during a process
called the respiratory burst, which involves an increase in cellular
oxygen consumption and the reduction of molecular oxygen to superoxide (O2
). Activated macrophages can also produce
RNIs via the high-output inducible nitric oxide synthase enzyme (iNOS),
which oxidizes L-arginine to yield nitric oxide (NO) and
citrulline (45). Resident or gamma interferon
(IFN-
)-primed macrophages do not express iNOS and therefore do not
produce measurable levels of RNIs. In contrast, activated macrophages
constitutively secrete high levels of RNIs (35). Both ROIs
and RNIs are individually capable of mediating microbial killing by
macrophages. Several early studies have pointed to a primary role for
oxygen radicals in host defense. In several different experimental
systems, including cell-free oxygen-generating enzyme systems and, more
recently, gene-knockout mice lacking a component of the respiratory
burst enzyme complex, oxygen radical formation has been shown to
participate in the killing of a diverse group of pathogens, including
the promastigote form of Leishmania donovani
(32), Toxoplasma gondii (33), Plasmodium falciparum (44), and
Staphylococcus aureus (19, 27).
More recent studies have focused on the role of nitrogen radicals as
the primary macrophage microbicidal mediator. Again, using a variety of
experimental approaches, NO and its congeners have been shown to kill
both intracellular and extracellular, as well as both gram-negative and
-positive, bacteria. Consistent with these observations, mice lacking
the inducible NO synthase by gene targeting or mice treated with
inhibitors of iNOS are generally much more susceptible to infection by
a diverse variety of microorganisms (34). This increased
susceptibility implicates NO in microbial killing by macrophages;
however, it does not indicate precisely which molecules generated via
the iNOS pathway are responsible for microbial killing.
Evidence is now developing that the combination of the two
radical-generating systems may exert a synergistic effect in the killing of some microorganisms (10). Macrophages can
generate superoxide simultaneously with NO, yielding the more reactive peroxynitrite (ONOO
) (18). This compound has
been shown to possess greater toxicity than NO for Escherichia
coli (5), Salmonella enterica serovar Typhimurium (8), Mycoplasma pulmonis
(14), and Candida albicans (43). In
these experimental model systems, both oxygen and nitrogen radicals are
required to mediate maximal microbicidal effects. In other experimental
systems, however, NO appears to be more toxic than ONOO
.
This is true of Leishmania major (1),
Giardia lamblia (11), and Cryptococcus
neoformans (42). All of these organisms are susceptible
to NO, and the addition of superoxide to NO to yield peroxynitrite
lowers NO concentrations and reduces toxicity against these organisms.
In the present studies, we investigate the killing of R. equi by activated macrophages. We examine the requirement for
macrophage activation and the relative potency of oxygen and nitrogen
radicals in mediating bacterial killing. We demonstrate that mice
deficient in either of the two radical-generating pathways are
hypersusceptible to infection and that neither
O2
nor NO is sufficient to kill R. equi in vitro. The combination of both radicals, however, to form
peroxynitrite results in the efficient and rapid killing of R. equi cells by activated macrophages. We visualize
ONOO
formation in situ in activated macrophages
phagocytizing R. equi.
 |
MATERIALS AND METHODS |
Bacteria.
R. equi 238 is a clinical isolate obtained
from a pneumonic foal and provided by the Veterinary Microbiology
Laboratory, New Bolton Center, University of Pennsylvania, Kennett
Square. Bacteria were stored in 15% glycerol at
70°C. Prior to
use, bacteria were streaked onto chocolate agar plates and grown at
37°C for 36 h. For all assays, one isolated colony of bacteria
was inoculated into 10 ml of Mueller-Hinton broth and cultured
overnight at 37°C. Bacterial cultures were grown to a density of
approximately 108 per ml. Before their addition to
macrophages, bacteria were washed with phosphate-buffered saline (PBS)
and resuspended in phagocytosis buffer, which consisted of 1% gelatin
in equal parts Dulbecco's modified Eagle medium and Media 199 (Mediatech, Herndon, Va.) buffered with 12.5 M HEPES.
Mice.
Four- to 6-week-old female BALB/c, C57BL/6,
C57BL/6-NOS2tm1Lau (iNOS
/
)
(26), and C57BL/6-Ifngtm1Ts
(IFN-
/
) (7) mice were obtained from the
Jackson Laboratory (Bar Harbor, Maine). The
gp91phox
/
mice (19) were a
generous gift from Mary C. Dinauer (Indiana University, Indianapolis).
Mouse infections.
Frozen stocks of R. equi were
thawed in 3 ml of Mueller-Hinton broth at 37°C for 3 h and then
washed and resuspended in cold Hanks' balanced salt solution. Mice
were infected intravenously with a 100-µl volume of PBS containing
3 × 106 to 9 × 106 viable bacteria.
Bacterial burdens in the liver, spleen, and lung were determined at
various days postinfection. Organs were harvested from infected mice,
homogenized in 10 ml of cold water, diluted, and plated onto chocolate
agar plates. After incubation of plates at 37°C for 36 h, the
CFU recovered from each organ were determined. For viability assays,
infected mice were monitored daily and the days on which mice succumbed
to infection were recorded.
Cell-free bactericidal assays.
For all cell-free
bactericidal assays, virulent R. equi was grown overnight at
37°C, washed once, and resuspended in 50 mM potassium phosphate
buffer (pH 7.4). Bacteria were exposed to 1 mM diethylamine-nitric
oxide (DEA/NO; Calbiochem, San Diego, Calif.). DEA/NO is a stable
complex in solid form which decomposes quickly
(t1/2 = 2.1 min) at 37°C in phosphate
buffer (pH 7.4) to release 1.5 mol of NO per mol of compound
(29). A fresh, 40 mM solution of DEA/NO was prepared in
ice-cold 0.01 M sodium hydroxide to minimize decomposition. DEA/NO was
diluted 40-fold into 1 ml of phosphate buffer containing
106 viable bacteria. NO release from DEA/NO was measured by
using the Griess reagent as previously described (9).
Inactive DEA/NO was decomposed in phosphate buffer for 30 min before
addition to bacteria. One unit of xanthine oxidase (Sigma Chemical Co., St. Louis, Mo.) was used to convert 5 mM xanthine (Sigma) to uric acid,
releasing superoxide anion (O2
)
(2). Bacteria, xanthine, and xanthine oxidase were combined in a 1.5-ml reaction volume and incubated at 37°C for 30 min. O2
generation was measured by the reduction
of cytochrome c as previously described (20).
Peroxynitrite (ONOO
) was synthesized in a quenched-flow
reactor from nitrite and hydrogen peroxide as previously described
(3) and stored at
70°C until used. The millimolar
concentration of ONOO
was determined before each
experiment by using the following calculation: [(OD302 in
1 M NaOH
OD302 in 50 mM phosphate buffer) × dilution × 1,000]/1,670 (3), where OD302
is the optical density at 302 nm. ONOO
was added to
bacteria in a 1-ml reaction volume at a final concentration of 1 mM for
1 min at 37°C. Because the half-life of ONOO
is less
than 1 s in phosphate buffer (pH 7.4) at 37°C, inactive ONOO
was prepared by allowing ONOO
decomposition to nitrate in phosphate buffer for 5 min before addition
to bacteria. Following exposure to each compound (DEA/NO, X-XO,
ONOO
), bacteria were centrifuged, resuspended in
phosphate buffer, and exposed for a second and third time prior to
dilution plating for CFU quantitation.
The intracellular growth of R. equi in
macrophages.
Bone marrow-derived macrophages (BMM
) were
established as described previously (41). Briefly, bone
marrow was flushed from the femurs of mice by using 4 ml of cold PBS
(Mediatech) and a 23-gauge needle. Cells were resuspended in
Dulbecco's modified Eagle medium supplemented with 10% fetal calf
serum (D-10) and 20% L929-conditioned media as a source of
colony-stimulating factor. Cells were incubated 5 to 7 days at 37°C
with 5% CO2 in plastic petri dishes until monolayers
became confluent. BMM
were removed from plates by using 5 mM EDTA,
resuspended in D-10, and adhered to glass coverslips in 24-well plates.
Following a 1-h incubation, cells were washed with antibiotic-free D-10
and incubated overnight. Macrophages (approximately 105 per
coverslip) were either unstimulated or stimulated in vitro for 18 to
24 h with 100 U of IFN-
(Genzyme, Cambridge, Mass.) per ml and
50 ng of lipopolysaccharide (LPS) (E. coli 0127:B8) (Sigma)
per ml in the presence or absence of 500 µM
NG-monomethyl-L-arginine (NMLA) (Calbiochem).
Bacteria were added to washed macrophage monolayers at a multiplicity
of infection (MOI) of 5 to 10 bacteria per macrophage in the presence
of 5% fresh normal mouse serum as a source of complement. After a
30-min incubation with bacteria, monolayers were washed with warm
phagocytosis buffer to remove any unbound bacteria from wells. An
additional 30-min incubation was performed to allow bacteria sufficient
time to be internalized by macrophages, followed by washing and
replacement of media with D-10 supplemented with 5 to 10 µg of
gentamicin sulfate (GIBCO/BRL, Rockville, Md.) per ml. This
concentration of gentamicin sulfate kills extracellular bacteria while
minimally affecting intracellular bacteria, as described previously
(16). At various times postinfection, macrophage monolayers
were fixed in 100% methanol (20 min, 4°C) and the bacteria associated with macrophages were stained by immunofluorescence using
rabbit antiserum to R. equi, as previously described
(16). The total number of bacteria associated with 200 macrophages per monolayer were quantitated by using fluorescence
microscopy. Because of the difficulty in counting individual bacteria
within large clusters, macrophages containing large clusters of
bacteria were recorded simply as having 10 bacteria per cell. Results
are presented as the total number of bacteria per 200 macrophages
and/or the number of macrophages containing 10 or more bacteria.
The visualization of ONOO
production by
macrophages.
Intracellular ONOO
production was
visualized by using dihydrorhodamine (DHR)-123 (Molecular Probes,
Eugene, Ore.) as previously described (17). DHR was prepared
as a 10-mg/ml stock in dimethylformamide, purged with nitrogen, and
stored in aliquots at
20°C. BMM
were cultured overnight in
24-well plates in antibiotic-free, phenol red-free D-10 containing 100 U of IFN-
/ml and 50 ng of LPS/ml with or without 500 µM NMLA
(Calbiochem). Cells were washed and media was replaced with
antibiotic-free, phenol red-free D-10 containing 1 mM DHR and 5%
normal mouse serum. Bacteria from an overnight culture were added to
macrophage monolayers at an MOI of 50:1 for 15 min at 37°C. This
relatively high MOI was used to achieve a higher level of infection in
the majority of cells in the monolayer. Intracellular
ONOO
-mediated oxidation of DHR was visualized as
rhodamine fluorescence in an Olympus inverted microscope. The number of
fluorescing macrophages was counted and expressed as the percent of
positive cells in the population.
 |
RESULTS |
Rhodococcus infection in IFN-
/
,
iNOS
/
, and gp91phox
/
mice.
R. equi infections were examined in mice lacking key
components of host defense. Infections in mice lacking IFN-
production (IFN
/
), high-output nitric oxide
production (iNOS
/
), or superoxide production
(gp91phox
/
) were compared to infections in
normal C57BL/6 mice. The survival of mice injected intravenously with
3 × 106 virulent R. equi cells was
followed over 15 days. This inoculum is approximately 1/10 of the 50%
lethal dose (data not shown), and consequently, all wild-type C57BL/6
mice survived the infection (Fig. 1). In
contrast, knockout mice were highly susceptible to this relatively low
inoculum of R. equi. iNOS
/
mice were most
susceptible, with all of the mice succumbing by 7.5 days postinfection.
Half of the gp91phox
/
mice succumbed to
infection by day 8 and all were dead by 9.5 days postinfection.
Although IFN-
/
mice survived slightly longer than
the iNOS
/
or gp91phox
/
mice,
by 10 days, half of the IFN-
knockout (GKO) mice were dead, and by
13 days postinfection, 80% had succumbed to R. equi infection (Fig. 1). The increased mortality observed in knockout mice
corresponded with an increase in bacterial burdens in their visceral
organs (Fig. 2). Organ burdens from
wild-type and IFN-
/
mice were determined at 0, 3, and 7 days following intravenous infection. By 7 days, CFU recovered
from liver, spleen, and lungs of IFN-
/
mice were
approximately 600-, 1,100-, and 250,000-fold higher, respectively, than
those recovered from organs of wild-type mice (Fig. 2). At 5 days
postinfection, organ burdens from iNOS
/
and
gp91phox
/
mice were also dramatically
increased relative to those of wild-type mice (data not shown). These
mice did not survive for 7 days, precluding an analysis of this later
time point.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 1.
R. equi infection in
IFN- / , gp91phox / , and
iNOS / mice. C57BL/6 (n = 7),
IFN- / (n = 8),
gp91phox / (n = 5), and
iNOS / (n = 7) mice were infected
intravenously with virulent R. equi (3 × 106 cells). Data are taken from a single experiment in
which all groups were included in parallel. The data are representative
of three separate experiments including a total of 18 mice per
group.
|
|

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 2.
CFU recovered from organs of IFN- /
and C57BL/6 mice following R. equi infection.
IFN- / mice (squares) and wild-type littermates
(circles) were infected intravenously with virulent R. equi
(9 × 106 cells). Bacterial burdens in the liver
(top), spleen (middle), and lung (bottom) were determined at 0, 3, and
7 days postinfection. Each data point represents CFU (± standard
deviation) of five mice per group. *, significantly different from
control mice (P 0.008; Mann-Whitney U test).
|
|
The in vitro generation of NO and
O2
.
Our in vivo observations suggested
that both oxygen and nitrogen radicals can contribute to host defense
to R. equi. We directly measured bacterial susceptibility to
oxygen and nitrogen radicals utilizing cell-free radical-generating
systems. The NO-releasing compound DEA/NO (29) was used to
test the susceptibility of R. equi to NO, while the
xanthine-xanthine oxidase (X-XO) enzymatic system (2) was
used to generate O2
. The viability of
R. equi following one, two, or three 30-min exposures to
either NO or O2
was determined. No decrease
in bacterial viability was observed even after three consecutive
prolonged exposures to either DEA/NO or X-XO (Fig.
3A). Bacterial numbers remained
relatively constant throughout and were not decreased relative to those
of unexposed bacteria or to bacteria exposed to inactive DEA/NO, which
does not release NO (Fig. 3A). Radical generation by these cell-free systems was quantitated in parallel to assure that the lack of bacterial killing was not due to a failure to generate radicals in
these systems. A concentration of 1 mM DEA/NO yielded >1.5 mM NO
(measured as nitrite accumulation) and 1 U of xanthine oxidase yielded
>40 nmol of O2
from 5 mM xanthine over 30 min in these systems (Fig. 3B and C, respectively). In similar,
cell-free experiments, acidified nitrite or hydrogen peroxide at
concentrations as high as 10 mM also failed to kill R. equi
(data not shown). The interpretation drawn from these experiments is
that neither nitrogen nor oxygen radicals alone were sufficient to
mediate a bactericidal effect.

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 3.
R. equi exposure to NO released by DEA/NO or
O2 generated by X-XO. (A) R. equi
(106 cells) was exposed to 1 mM inactive or active DEA/NO
or 1 U of xanthine oxidase and 5 mM xanthine (hatched bar). Following a
30-min incubation at 37°C, bacteria were centrifuged, resuspended,
and reexposed to X-XO or DEA/NO for a second and third time. Control
samples were incubated in phosphate buffer alone. Cell viability was
determined by a CFU assay. The data are representative of three
separate experiments. (B) The amount of NO released by DEA/NO was
determined by using the Griess reagent (9) following the
incubation of 1, 2.5, or 5 mM DEA/NO in phosphate buffer at 37°C for
30 min. (C) Increasing amounts of xanthine oxidase were added to
phosphate buffer containing 5 mM xanthine in the presence of cytochrome
c. The amount of O2 generated was
determined following a 30-min incubation at 37°C by measuring the
reduction of cytochrome c (20). Xanthine oxidase
which had been boiled for 15 min was used as a control.
|
|
The in vitro killing of R. equi by
ONOO
.
Peroxynitrite (ONOO
) is a strong
oxidant that is generated from the spontaneous reaction of NO and
O2
(18). We examined the
susceptibility of R. equi to ONOO
in a
cell-free system (Fig. 4). The viability
of R. equi following one, two, or three 1-min exposures to 1 mM active or inactive ONOO
was examined. This
concentration of ONOO
is biologically relevant based on
calculations from the formation of ONOO
by rat alveolar
macrophages in the lung lining fluid and in phagolysosomes of
macrophages (18). Following a single 1-min exposure to
active ONOO
, bacterial viability was not significantly
decreased relative to that of untreated controls. However, following a
second exposure to ONOO
, bacterial viability had
decreased by >2 logs. No bacterial CFU were recovered after the third
1-min exposure to active ONOO
, indicating complete
bacterial killing by ONOO
(Fig. 4). As expected, exposure
of bacteria to inactive ONOO
did not affect their
viability (Fig. 4). These data demonstrate that even brief exposures of
R. equi to ONOO
in a cell-free system can
result in complete bacterial killing.

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 4.
Exposure of R. equi to ONOO .
R. equi (106 cells) in 50 mM potassium phosphate
buffer was exposed to 1 mM active peroxynitrite. Following a 1-min
incubation at 37°C, bacteria were centrifuged, resuspended, and
reexposed to ONOO for a second and third time. Control
(untreated) samples were incubated in phosphate buffer alone or with
inactive ONOO which had completely decomposed prior to
addition to bacteria. Cell viability was determined by a CFU assay.
Data shown are means (± standard deviation) of triplicate samples and
are representative of three independent experiments. *, significantly
different from untreated samples (P < 0.001;
Student's t test).
|
|
Quantitation of Rhodococcus replication inside
activated macrophages.
We performed in vitro studies to measure
R. equi killing by activated macrophages. BMM
monolayers
were activated with IFN-
and LPS and infected with R. equi. Infection at an MOI of 5 to 10 bacteria per macrophage
resulted in approximately 50% of macrophages being infected with an
average of 1 or 2 bacteria per cell. Bacterial growth in macrophages
was examined over a 72-h period. Nonactivated (untreated) macrophages
supported the replication of R. equi cells (Fig.
5A), as previously described
(16). Bacterial replication resulted in a progressive
increase both in the total number of bacteria per 200 macrophages (Fig.
5A) and the in number of macrophages infected with 10 or more bacteria
(Fig. 5A). In activated macrophages, in contrast, both the total number
of bacteria and the number of macrophages with
10 bacteria remained
relatively constant throughout the observation period (Fig. 5A). These
data show that macrophages activated with IFN-
and LPS restrict the
intracellular growth of R. equi in vitro.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 5.
Quantitation of R. equi growth within
activated wild-type, iNOS / , and
gp91phox / macrophages. BMM were either
untreated or activated overnight with 100 U of IFN- /ml plus 50 ng of
LPS/ml before infection with R. equi at an MOI of between 5 and 10 bacteria per macrophage. At 1, 24, 48, and 72 h
postinfection, parallel macrophage monolayers were washed, fixed, and
stained for fluorescence microscopy. (A) R. equi replication
inside untreated and activated BALB/c BMM was quantitated. Bacterial
growth was expressed as both the total number of bacteria per 200 macrophages (solid lines, left axis) and the number of macrophages
containing 10 bacteria (dashed lines, right axis). Each data point
shown represents the mean (± standard error of the mean) of three
separate experiments done in triplicate. At all time points (24 to
72 h), bacterial numbers in activated macrophages were
statistically different from those in untreated macrophages
(P 0.001; Mann-Whitney U test). (B) The replication
of R. equi inside untreated or activated macrophages from
iNOS / or gp91phox / mice was
quantitated. Data represent the number of macrophages infected with 10 or more bacteria. Each point represents the mean (± standard error of
the mean) of 3 experiments counted in triplicate except for 72-h
iNOS / , which represents a triplicate sample from a single
experiment.
|
|
Because the generation of ONOO
requires the production of
both NO and O2
, we examined the capacity of
BMM
from iNOS
/
or
gp91phox
/
mice to inhibit R. equi
replication in vitro following activation with IFN-
and LPS (Fig.
5B). As expected, bacterial replication occurred in nonactivated
macrophages from both mice and the extent of replication was comparable
to that observed in nonactivated wild-type macrophages (Fig. 5A and B).
Macrophages which cannot produce NO (iNOS
/
) were unable
to restrict R. equi replication, even after IFN-
and LPS
activation (Fig. 5B, solid lines). Surprisingly, however, activated
gp91phox
/
macrophages were fully capable of
restricting intracellular R. equi replication (Fig. 5B,
dashed lines), despite their inability to mount a respiratory burst. We
hypothesized that other sources of cellular oxygen radicals were
contributing to ONOO
formation and bacterial killing, but
our attempts to reverse bacterial killing by treating macrophages with
a variety of oxygen radical inhibitors were not consistently successful
(data not shown).
The production of ONOO
by activated macrophages.
To visualize ONOO
production by macrophages phagocytizing
R. equi, monolayers of resident or activated macrophages
were incubated with DHR prior to the addition of opsonized R. equi. In the presence of ONOO
, DHR is oxidized to
fluorescent rhodamine (17). This technology was used to
visualize ONOO
formation in situ, during bacterial
phagocytosis. A dull and equivalent level of background fluorescence
was evident in all of the control monolayers that were tested,
including resident uninfected cells (Fig.
6A). However, activated macrophages to which R. equi was added exhibited a rapid increase in
fluorescence intensity, indicating ONOO
production. This
production was evident even in low-magnification photomicrographs in
which virtually all of the cells phagocytizing R. equi cells
were brightly fluorescent (Fig. 6A). More than 50% of the cells in the
monolayer stained positively for ONOO
(Fig. 6B). In
contrast, the phagocytosis of R. equi cells by resident
(nonactivated) macrophages failed to produce ONOO
. The
magnitude of fluorescence was indistinguishable from background levels
(Fig. 6A), and the number of cells producing ONOO
was not
different from that of uninfected cells. Activated, infected cells
treated with NMLA to inhibit NO production failed to produce ONOO
(Fig. 6B), and these cells failed to restrict
R. equi growth in vitro (Fig. 6B, inset).


View larger version (3423K):
[in this window]
[in a new window]
|
FIG. 6.
Peroxynitrite formation by activated, R. equi-infected macrophages. (A) Monolayers of BMM were either
untreated or activated overnight with 100 U of IFN- /ml and 50 ng of
LPS/ml in the presence or absence of NMLA. R. equi was added
to monolayers at an MOI of 50:1 in the presence of 1 mM DHR for 15 min
at 37°C. Uninfected cells were treated similarly but were not
infected with R. equi. Monolayers were analyzed for
rhodamine fluorescence and photographed on an inverted microscope. (B)
The number of cells positive for rhodamine fluorescence was quantitated
and expressed as a percent positive. These data are representative of
three independent experiments. (Inset) The intracellular growth of
R. equi in resident cells (closed circles), activated cells
(open circles), or activated cells treated with 500 µM NMLA
(squares). Bacterial numbers are statistically different between
macrophages activated with or without NMLA at 24 and 48 h
(P 0.04; Student's t test).
|
|
 |
DISCUSSION |
R. equi is an intracellular bacterium that
resides primarily within host macrophages. Previous studies have
demonstrated that R. equi can replicate in nonactivated
resident macrophages in vitro (16). Because the murine model
has been established as an appropriate system to study R. equi infection (15), both in vivo and in vitro studies
were developed to provide a better understanding of the role of the
activated macrophage in R. equi infection. Studies in mice
lacking the gene for IFN-
were undertaken to address the requirement
of IFN-
for R. equi clearance in vivo. GKO mice were
hypersusceptible to lethal R. equi infection and had
increased bacterial burdens in their livers, spleens, and lungs at 3 and 7 days postinfection relative to those of wild-type mice. The most
significant differences were seen in the lung at 7 days postinfection,
when bacterial burdens in GKO mice were 5 logs higher than those
observed in normal mice. Thus, IFN-
plays a central role in host
defense to R. equi. This observation is similar to that seen
when GKO mice were infected with other intracellular pathogens,
including another nocardioform actinomycete, Mycobacterium
tuberculosis (6, 12). These studies confirm and extend
the previous results of Kanaly et al., which showed that treatment of
mice with anti-IFN-
exacerbated disease (22). The
requirement for IFN-
confirms initial correlations between Th1-type
immune responses and efficient resolution of experimental R. equi disease in mice (22, 24) and establishes the
activated macrophage as the principal cell type involved in host
defense against R. equi.
Studies were undertaken to identify the mechanism whereby activated
macrophages killed R. equi. Oxygen and nitrogen radicals were the focus of this work. The generation of ROIs by macrophages occurs during the phagocytosis of many bacteria, fungi, and protozoa (25). Resident macrophages have some capacity to undergo a
respiratory burst, but immunologic activation of macrophages augments
this process substantially. The production of NO occurs only in
activated macrophages. IFN-
is the primary signal for iNOS
transcription; however, secondary signals, such as tumor necrosis
factor alpha, that are induced following the exposure of macrophages to
bacterial products are generally also required for NO production. The
role of oxygen and nitrogen radicals in bacterial killing was examined in vivo in animals deficient in the production of either of these radicals and in vitro in cell-free radical-generating systems. Because
mice lacking iNOS failed to clear bacteria and succumbed to what should
have been a sublethal infection, our initial studies focused on NO and
its congeners in killing R. equi. Several subsequent observations, however, were not consistent with NO alone being directly
bactericidal to R. equi. The failure of NO generated in a
cell-free system to kill R. equi and the in vivo observation that gp91phox
/
mice were also susceptible to
lethal R. equi infection suggested a more complex mechanism
of bacterial killing by activated macrophages, which involved oxygen as
well as nitrogen radicals. These observations prompted us to examine
the role of peroxynitrite in bacterial killing.
To examine peroxynitrite-mediated killing of R. equi, small
amounts of ONOO
(1 mM) were added directly to viable
R. equi organisms in a cell-free system. This concentration
represents a low net exposure because, at physiological pH,
ONOO
rapidly decomposes to nitrate. Taking into account
the short half-life of ONOO
, a single bolus of 1 mM
ONOO
is equivalent to a steady-state concentration of
approximately 28 µM (46). This level of ONOO
is therefore comparable to levels produced in situ, since rat alveolar
macrophages within the lung epithelial lining fluid can produce up to 1 mM peroxynitrite min
1 (18). Furthermore,
concentrations of peroxynitrite surrounding a bacterium in the
phagolysosome may actually be higher (18). The toxicity of
ONOO
for bacteria has been well documented
(10). This strong oxidant can cause membrane damage via
lipid peroxidation (40) and can damage DNA (21),
oxidize sulfhydryl groups (38), and mediate tyrosine
nitration (4). In the present work, we not only show that
R. equi is very sensitive to brief exposures to
ONOO
but also demonstrate that activated (but not
resident) macrophages produce ONOO
during bacterial
phagocytosis. This is a direct demonstration of ONOO
production by macrophages during bacterial phagocytosis. The production
of ONOO
occurred only in macrophages undergoing
phagocytosis and only when the macrophages were activated by IFN-
.
In summary, we have shown that while NO is required for R. equi killing, this radical alone cannot mediate bacterial killing. Even large concentrations of NO (5 mM [data not shown]) for extended periods of time under a variety of conditions (acidic and neutral pH
[data not shown]) were unable to inhibit bacterial growth. The
combination of NO with O2
to form
ONOO
, however, was potently bactericidal to R. equi, demonstrating a synergy between ROIs and RNIs. These studies
reinforce a two-step model for the efficient killing R. equi
by activated macrophages. The first step is macrophage activation which
is typically mediated by IFN-
and tumor necrosis factor alpha
(24). This activation induces the transcription of iNOS mRNA
and results in constitutive NO production. The second signal is
provided by the bacteria themselves, which stimulate the respiratory
burst during the process of phagocytosis. The high levels of
O2
produced by cells undergoing bacterial
phagocytosis combines with NO produced by activated macrophages to form
ONOO
, which kills R. equi.
 |
ACKNOWLEDGMENTS |
This work was supported in part by a grant from The Grayson
Jockey Club Research Foundation.
We are grateful to John Chan (Albert Einstein College of Medicine,
Bronx, N.Y.) for his assistance with the generation of peroxynitrite.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, Temple University School of Medicine, 3400 N. Broad St., Philadelphia, PA 19140. Phone: (215) 707-8262. Fax: (215)
707-7788. E-mail: dmmosser{at}astro.temple.edu.
Editor:
W. A. Petri Jr.
 |
REFERENCES |
| 1.
|
Assreuy, J.,
F. Q. Cunha,
M. Epperlein,
A. Noronha-Dutra,
C. A. O'Donell,
F. Y. Liew, and S. Moncada.
1994.
Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major.
Eur. J. Immunol.
24:672-676[Medline].
|
| 2.
|
Babior, B. M.,
J. T. Curnette, and R. S. Kipnes.
1975.
Biological defense mechanisms. Evidence for the participation of superoxide in bacterial killing by xanthine oxidase.
J. Lab. Clin. Med.
85:235-244[Medline].
|
| 3.
|
Beckman, J. S.,
T. W. Beckman,
J. Chen,
P. A. Marshall, and B. A. Freeman.
1990.
Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.
Proc. Natl. Acad. Sci. USA
87:1620-1624[Abstract/Free Full Text].
|
| 4.
|
Beckman, J. S.,
H. Ischiropoulos,
L. Zhu,
M. van der Woerd,
C. Smith,
J. Chen,
J. Harrison,
J. C. Martin, and M. H. Tsai.
1992.
Kinetics of superoxide dismutase and iron catalyzed nitration of phenolics by peroxynitrite.
Arch. Biochem. Biophys.
298:431-437[CrossRef][Medline].
|
| 5.
|
Brunelli, L.,
J. P. Crow, and J. S. Beckman.
1995.
The comparative toxicity of nitric oxide and peroxynitrite to Escherichia coli.
Arch. Biochem. Biophys.
316:327-334[CrossRef][Medline].
|
| 6.
|
Cooper, A. M.,
D. K. Dalton,
T. A. Stewart,
J. P. Griffin,
D. G. Russell, and I. M. Orme.
1993.
Disseminated tuberculosis in interferon gene-disrupted mice.
J. Exp. Med.
178:2243-2247[Abstract/Free Full Text].
|
| 7.
|
Dalton, D. K.,
S. Pitts-Meek,
S. Keshav,
I. S. Figari,
A. Bradley, and T. A. Stewart.
1993.
Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.
Science
259:1739-1745[Abstract/Free Full Text].
|
| 8.
|
DeGroote, M. A.,
D. Granger,
Y. Xu,
G. Cambell,
R. Prince, and F. C. Fang.
1995.
Genetic and redox determinants of nitric oxide cytotoxicity in a Salmonella typhimurium model.
Proc. Natl. Acad. Sci. USA
92:6399-6403[Abstract/Free Full Text].
|
| 9.
|
Ding, A. H.,
C. F. Nathan, and D. J. Stuehr.
1988.
Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages.
J. Immunol.
141:2407-2412[Abstract].
|
| 10.
|
Fang, F. C.
1997.
Mechanisms of nitric oxide-related anti-microbial activity.
J. Clin. Investig.
99:2818-2825[Medline].
|
| 11.
|
Fernandes, P. D., and J. Assreuy.
1997.
Role of nitric oxide and superoxide in Giardia lamblia killing.
Braz. J. Med. Biol. Res.
30:93-99[Medline].
|
| 12.
|
Flynn, J. L.,
J. Chan,
K. J. Triebold,
D. K. Dalton,
T. A. Stewart, and B. R. Bloom.
1993.
An essential role for interferon in resistance to Mycobacterium tuberculosis infection.
J. Exp. Med.
178:2249-2254[Abstract/Free Full Text].
|
| 13.
|
Giguère, S., and J. S. Prescott.
1997.
Clinical manifestations, diagnosis, treatment and prevention of R. equi infections in foal.
Vet. Microbiol.
56:313-334[CrossRef][Medline].
|
| 14.
|
Hickman-Davis, J.,
J. Gibbs-Erwin,
J. R. Lindsey, and S. Matalon.
1999.
Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages by production of peroxynitrite.
Proc. Natl. Acad. Sci. USA
96:4953-4958[Abstract/Free Full Text].
|
| 15.
|
Hondalus, M. K.
1997.
Pathogenesis and virulence of Rhodococcus equi.
Vet. Microbiol.
56:257-268[CrossRef][Medline].
|
| 16.
|
Hondalus, M. K., and D. M. Mosser.
1994.
Survival and replication of Rhodococcus equi in macrophages.
Infect. Immun.
62:4167-4175[Abstract/Free Full Text].
|
| 17.
|
Ischiropoulos, H.,
A. Gow,
S. R. Thom,
N. W. Kooy,
J. A. Royall, and J. P. Crow.
1999.
Detection of reactive nitrogen species using 2,7-dichlorodihydrofluorescein and dihydrorhodamine 123.
Methods Enzymol.
301:367-373[Medline].
|
| 18.
|
Ischiropoulos, H.,
L. Zhu, and J. S. Beckman.
1992.
Peroxynitrite formation from macrophage-derived nitric oxide.
Arch. Biochem. Biophys.
298:446-451[CrossRef][Medline].
|
| 19.
|
Jackson, S. H.,
J. I. Gallin, and S. M. Holland.
1995.
The gp91phox mouse knock-out model of chronic granulomatous disease.
J. Exp. Med.
182:751-758[Abstract/Free Full Text].
|
| 20.
|
Johnston, R. B.,
C. A. Godzik, and Z. A. Cohn.
1978.
Increased superoxide anion production by immunologically activated and chemically elicited macrophages.
J. Exp. Med.
148:115-127[Abstract/Free Full Text].
|
| 21.
|
Juedes, M. J., and G. N. Wogan.
1996.
Peroxynitrite-induced mutation spectra of pSP189 following replication in bacteria and in human cells.
Mutat. Res.
349:51-61[Medline].
|
| 22.
|
Kanaly, S. T.,
S. A. Hines, and G. H. Palmer.
1995.
Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatuous pneumonia.
Infect. Immun.
63:3037-3041[Abstract].
|
| 23.
|
Kanaly, S. T.,
S. A. Hines, and G. H. Palmer.
1996.
Transfer of a CD4+ Th1 cell line to nude mice effects the clearance of Rhodococcus equi from the lung.
Infect. Immun.
64:1126-1132[Abstract].
|
| 24.
|
Kasuga-Aoki, H.,
S. Takai,
Y. Sasaki,
S. Tsubaki,
H. Madarame, and A. Nakane.
1999.
Tumour necrosis factor and interferon- are required in host resistance against virulent Rhodococcus equi infection in mice: cytokine production depends on the virulence levels of R. equi.
Immunology
96:122-127[CrossRef][Medline].
|
| 25.
|
Klebanoff, S. J.
1980.
Oxygen metabolism and the toxic properties of phagocytes.
Ann. Intern. Med.
93:480-489.
|
| 26.
|
Laubach, V. E.,
E. G. Shesely,
O. Smithies, and P. A. Sherman.
1995.
Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death.
Proc. Natl. Acad. Sci. USA
92:10688-10692[Abstract/Free Full Text].
|
| 27.
|
Leijh, P. C. J.,
C. F. Nathan,
M. T. H. van den Barselaar, and R. van Furth.
1985.
Relationship between extracellular stimulation of intracellular killing and oxygen-dependent microbicidal systems of monocytes.
Infect. Immun.
47:502-507[Abstract/Free Full Text].
|
| 28.
|
Madigan, J. E.,
S. Hietala, and N. Mueller.
1991.
Protection against naturally-acquired Rhodococcus equi pneumonia in foals by administration of hyperimmune plasma.
J. Reprod. Fertil. Suppl.
44:571-578[Medline].
|
| 29.
|
Maragos, C. M.,
D. Morley,
D. A. Wink,
T. M. Dunams,
J. E. Saavedra,
A. Hoffman,
A. A. Bove,
L. Isaac,
J. A. Hrabie, and L. K. Keefer.
1991.
Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide.
J. Med. Chem.
34:3243-3247.
|
| 30.
|
Martens, R. J.,
R. A. Fiske, and H. W. Renshaw.
1982.
Experimental subacute foal pneumonia induced by aerosol administration of Corynebacterium equi.
Equine Vet. J.
14:111-116[Medline].
|
| 31.
|
Martens, R. J.,
J. G. Martens,
R. A. Fiske, and S. K. Hietala.
1989.
Rhodococcus equi foal pneumonia. Protective effects of immune plasma in experimentally infected foals.
Equine Vet. J.
21:249-255[Medline].
|
| 32.
|
Murray, H. W.
1981.
Susceptibility of Leishmania to oxygen intermediates and killing by normal macrophages.
J. Exp. Med.
153:1302-1315[Abstract/Free Full Text].
|
| 33.
|
Murray, H. W., and Z. A. Cohn.
1979.
Macrophage oxygen-dependent antimicrobial activity. I. Susceptibility of Toxoplasma gondii to oxygen intermediates.
J. Exp. Med.
150:938-949[Abstract/Free Full Text].
|
| 34.
|
Nathan, C.
1997.
Inducible nitric oxide synthase: what difference does it make?
J. Clin. Investig.
100:2417-2423[Medline].
|
| 35.
|
Nathan, C., and J. B. Hibbs, Jr.
1991.
Role of nitric oxide synthesis in macrophage antimicrobial activity.
Curr. Opin. Immunol.
3:65-75[CrossRef][Medline].
|
| 36.
|
Nordmann, P.,
E. Ronco, and C. Nauciel.
1992.
Role of T-lymphocyte subsets in R. equi infection.
Infect. Immun.
60:2748-2752[Abstract/Free Full Text].
|
| 37.
|
Paulnock, D. M.
1994.
The molecular biology of macrophage activation.
Immunol. Ser.
60:47-62[Medline].
|
| 38.
|
Radi, R.,
J. S. Beckman,
K. M. Bush, and B. A. Freeman.
1991.
Peroxynitrite mediated sulfhydryl oxidation: the cytotoxic potential of superoxide and nitric oxide.
J. Biol. Chem.
266:4244-4250[Abstract/Free Full Text].
|
| 39.
|
Ross, T. L.,
G. A. Balson,
J. S. Miners,
G. D. Smith,
P. E. Shewen,
J. F. Prescott, and J. A. Yager.
1996.
Role of CD4+, CD8+, and double negative T-cells in the protection of SCID/beige mice against respiratory challenge with Rhodococcus equi.
Can. J. Vet. Res.
60:186-192[Medline].
|
| 40.
|
Rubbo, H.,
R. Radi,
M. Trujillo,
R. Telleri,
B. Kalyanaraman,
S. Barnes,
M. Kirk, and B. A. Freeman.
1994.
Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives.
J. Biol. Chem.
269:26066-26075[Abstract/Free Full Text].
|
| 41.
|
Sutterwala, F. S.,
G. J. Noel,
R. Clynes, and D. M. Mosser.
1997.
Selective suppression of interleukin-12 induction after macrophage receptor ligation.
J. Exp. Med.
185:1977-1985[Abstract/Free Full Text].
|
| 42.
|
Tohyama, M.,
K. Kawakami,
M. Futenma, and A. Saito.
1996.
Enhancing effect of oxygen radical scavengers on murine macrophage anticryptococcal activity through the production of nitric oxide.
Clin. Exp. Immunol.
103:436-441[CrossRef][Medline].
|
| 43.
|
Vasquez-Torres, A.,
J. Jones-Carson, and E. Balish.
1996.
Peroxynitrite contributes to the candidacidal activity of nitric oxide producing macrophages.
Infect. Immun.
64:3127-3133[Abstract].
|
| 44.
|
Wozencraft, A. O.,
H. M. Dockrell,
J. Taverne,
G. A. T. Targett, and J. H. L. Playfair.
1984.
Killing of human malaria parasites by macrophage secretory products.
Infect. Immun.
43:664-669[Abstract/Free Full Text].
|
| 45.
|
Xie, Q., and C. Nathan.
1994.
The high output nitric oxide pathway: role and regulation.
J. Leukoc. Biol.
56:576-582[Abstract].
|
| 46.
|
Zhu, L.,
C. Gunn, and J. S. Beckman.
1992.
Bactericidal activity of peroxynitrite.
Arch. Biochem. Biophys.
298:452-457[CrossRef][Medline].
|
Infection and Immunity, June 2000, p. 3587-3593, Vol. 68, No. 6
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Capparelli, R., Alfano, F., Amoroso, M. G., Borriello, G., Fenizia, D., Bianco, A., Roperto, S., Roperto, F., Iannelli, D.
(2007). Protective Effect of the Nramp1 BB Genotype against Brucella abortus in the Water Buffalo (Bubalus bubalis). Infect. Immun.
75: 988-996
[Abstract]
[Full Text]
-
Sheppard, F. R., Kelher, M. R., Moore, E. E., McLaughlin, N. J. D., Banerjee, A., Silliman, C. C.
(2005). Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation. J. Leukoc. Biol.
78: 1025-1042
[Abstract]
[Full Text]
-
Potter, S. M., Mitchell, A. J., Cowden, W. B., Sanni, L. A., Dinauer, M., de Haan, J. B., Hunt, N. H.
(2005). Phagocyte-Derived Reactive Oxygen Species Do Not Influence the Progression of Murine Blood-Stage Malaria Infections. Infect. Immun.
73: 4941-4947
[Abstract]
[Full Text]
-
Posen, Y., Kalchenko, V., Seger, R., Brandis, A., Scherz, A., Salomon, Y.
(2005). Manipulation of redox signaling in mammalian cells enabled by controlled photogeneration of reactive oxygen species. J. Cell Sci.
118: 1957-1969
[Abstract]
[Full Text]
-
Gillman, B. M., Batchelder, J., Flaherty, P., Weidanz, W. P.
(2004). Suppression of Plasmodium chabaudi Parasitemia Is Independent of the Action of Reactive Oxygen Intermediates and/or Nitric Oxide. Infect. Immun.
72: 6359-6366
[Abstract]
[Full Text]
-
Brennan, R. E., Russell, K., Zhang, G., Samuel, J. E.
(2004). Both Inducible Nitric Oxide Synthase and NADPH Oxidase Contribute to the Control of Virulent Phase I Coxiella burnetii Infections. Infect. Immun.
72: 6666-6675
[Abstract]
[Full Text]
-
Abedin, M., Tintut, Y., Demer, L. L.
(2004). Mesenchymal Stem Cells and the Artery Wall. Circ. Res.
95: 671-676
[Abstract]
[Full Text]
-
Darrah, P. A., Monaco, M. C. G., Jain, S., Hondalus, M. K., Golenbock, D. T., Mosser, D. M.
(2004). Innate Immune Responses to Rhodococcus equi. J. Immunol.
173: 1914-1924
[Abstract]
[Full Text]
-
Luhrmann, A., Mauder, N., Sydor, T., Fernandez-Mora, E., Schulze-Luehrmann, J., Takai, S., Haas, A.
(2004). Necrotic Death of Rhodococcus equi-Infected Macrophages Is Regulated by Virulence-Associated Plasmids. Infect. Immun.
72: 853-862
[Abstract]
[Full Text]
-
Master, S. S., Springer, B., Sander, P., Boettger, E. C., Deretic, V., Timmins, G. S.
(2002). Oxidative stress response genes in Mycobacterium tuberculosis: role of ahpC in resistance to peroxynitrite and stage-specific survival in macrophages. Microbiology
148: 3139-3144
[Abstract]
[Full Text]
-
Garton, N. J., Gilleron, M., Brando, T., Dan, H.-H., Giguere, S., Puzo, G., Prescott, J. F., Sutcliffe, I. C.
(2002). A Novel Lipoarabinomannan from the Equine Pathogen Rhodococcus equi. STRUCTURE AND EFFECT ON MACROPHAGE CYTOKINE PRODUCTION. J. Biol. Chem.
277: 31722-31733
[Abstract]
[Full Text]
-
Alam, M. S., Akaike, T., Okamoto, S., Kubota, T., Yoshitake, J., Sawa, T., Miyamoto, Y., Tamura, F., Maeda, H.
(2002). Role of Nitric Oxide in Host Defense in Murine Salmonellosis as a Function of Its Antibacterial and Antiapoptotic Activities. Infect. Immun.
70: 3130-3142
[Abstract]
[Full Text]
-
Aline, F., Bout, D., Dimier-Poisson, I.
(2002). Dendritic Cells as Effector Cells: Gamma Interferon Activation of Murine Dendritic Cells Triggers Oxygen-Dependent Inhibition of Toxoplasma gondii Replication. Infect. Immun.
70: 2368-2374
[Abstract]
[Full Text]
-
Musso, T., Badolato, R., Ravarino, D., Stornello, S., Panzanelli, P., Merlino, C., Savoia, D., Cavallo, R., Ponzi, A. N., Zucca, M.
(2001). Interaction of Bartonella henselae with the Murine Macrophage Cell Line J774: Infection and Proinflammatory Response. Infect. Immun.
69: 5974-5980
[Abstract]
[Full Text]
-
St. John, G., Brot, N., Ruan, J., Erdjument-Bromage, H., Tempst, P., Weissbach, H., Nathan, C.
(2001). Peptide methionine sulfoxide reductase from Escherichia coli and Mycobacterium tuberculosis protects bacteria against oxidative damage from reactive nitrogen intermediates. Proc. Natl. Acad. Sci. USA
10.1073/pnas.161295398v1
[Abstract]
[Full Text]
-
Eichert, K., Hamacher, J., Wunder, M. A., Wendel, A.
(2001). Intravasal Peroxynitrite Generation Causes Dysfunction in the Isolated Perfused Rat Lung via Endothelin. J. Pharmacol. Exp. Ther.
297: 128-132
[Abstract]
[Full Text]
-
John, G. St., Brot, N., Ruan, J., Erdjument-Bromage, H., Tempst, P., Weissbach, H., Nathan, C.
(2001). Peptide methionine sulfoxide reductase from Escherichia coli and Mycobacterium tuberculosis protects bacteria against oxidative damage from reactive nitrogen intermediates. Proc. Natl. Acad. Sci. USA
98: 9901-9906
[Abstract]
[Full Text]